黑料官网

header-logo
GettyImages-609179959-hero
headshot

Mehdi H. Hamadani, MD

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Urdu, Hindi, Punjabi

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Mehdi Hamadani, MD, is A a professor of medicine at the 黑料官网, Division of Hematology & Oncology, specializing in lymphoma, and bone marrow transplantation. Dr. Hamadani serves as the Director of the Adult Blood and Marrow Transplant Program (BMT) at Froedtert Hospital. He graduated from King Edward Medical College (with honors) in Pakistan in 2001, he then completed his internal medicine residency at Oklahoma University Health Sciences Center and a Fellowship in Hematology and Oncology at The Ohio State University. He received the James V. Warren Award for Accomplishments as The Most Outstanding Research Fellow, during his fellowship.

Research Interests

Dr. Hamadani has authored over 200 peer-reviewed publications, and has been invited as a speaker for several national and international meetings. He is the recipient of Conquer Cancer Foundation of ASCO Career Development Award and ASBMT New Investigator Award. Dr. Hamadani has also received several Best Attending Physician, Outstanding Teacher, Press Ganey Top Provider and Best Doctors in America Awards. His clinical research focuses on lymphoid malignancies and hematopoietic cell transplantation. Dr. Hamadani is board certified in Hematology and Medical Oncology.

Publications

  • (Salles G, Fox CP, Hamadani M, Wang A, Sail K, Alshreef A, Moran M, Mutebi A, Blaedel J, Chirikov V, Thieblemont C.) Clin Lymphoma Myeloma Leuk. 2025 Nov;25(11):e986-e994.e4 PMID: 40903324 PMCID: PMC12425561 09/04/2025

  • (Narvel H, Ahmed G, Hamadani M.) Expert Rev Hematol. 2025 Nov;18(11):935-944 PMID: 40767562 08/06/2025

  • (Ahmed N, Thiruvengadam SK, Hamadani M, Hu ZH, Grover N, Shadman M, Locke FL, Gerson J, Frank MJ, Budde LE, Wang M, Kim S, Bye M, Kharfan-Dabaja MA, Sauter C, Hematti P, Turtle CJ, Ahmed S, Moskop A, Logan B, Nunes A, Dalton D, Kloos I, Lee D, Xu H, Pasquini MC, Herrera AF.) Blood Adv. 2025 Oct 28;9(20):5382-5396 PMID: 40706035 PMCID: PMC12597645 SCOPUS ID: 2-s2.0-105022684848 07/24/2025

  • (Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, Jurdi NE, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M.) Transplant Cell Ther. 2025 Oct 07 PMID: 41027557 PMCID: PMC12606686 SCOPUS ID: 2-s2.0-105018107118 10/01/2025

  • (Gauthier J, Ahn KW, Patel J, Lian Q, Badawy S, Cairo MS, Delgado J, Grover N, Haverkos B, de Lima M, Malone A, Mussetti A, Nieto Y, Pawarode A, Pearson L, Solh M, Sureda A, Tun AM, Wudhikarn K, Yamshon S, Shadman M, Turtle CJ, Hamadani M, Herrera AF.) Am J Hematol. 2025 Oct;100(10):1792-1802 PMID: 40785644 PMCID: PMC12608806 SCOPUS ID: 2-s2.0-105012974565 08/11/2025

  • (Thiruvengadam SK, Ahn KW, Patel J, Lian Q, Hertzberg M, Epperla N, Metheny L, Hong S, Jain T, Aljurf M, Beitinjaneh A, Vaughn J, Gopal A, Iqbal M, Wirk B, Manjappa S, Oliver C, Mohty R, Shadman M, Turtle C, Hamadani M, Herrera AF.) Am J Hematol. 2025 Oct;100(10):1803-1812 PMID: 40762207 PMCID: PMC12582634 SCOPUS ID: 2-s2.0-105012595303 08/05/2025

  • (Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ.) Br J Haematol. 2025 Sep 22 PMID: 40983528 PMCID: PMC12519450 SCOPUS ID: 2-s2.0-105016816308 09/23/2025

  • (Hossain NM, Ahn KW, Patel J, Lian Q, Bilal Abid M, Al Nughmush A, Bacher U, Bi X, Hashmi SK, Hilal T, Husnain M, Khimani F, Maziarz RT, Modi D, Ram R, Rizzieri D, Sica RA, Steinberg A, Vij R, Shadman M, Turtle C, Hamadani M, Herrera AF.) Br J Haematol. 2025 Sep;207(3):1011-1018 PMID: 40693472 SCOPUS ID: 2-s2.0-105011357932 07/23/2025

  • (Shahzad M, Amin MK, Irfan S, Ahsan R, Qasim H, Javed MJ, McGuirk M, Chaudhary SG, Anwar I, Yacoub A, Singh AK, Hamadani M, Mcguirk JP, Mushtaq MU.) Clin Lymphoma Myeloma Leuk. 2025 Aug 17 PMID: 40930937 09/11/2025

  • (Shahzad M, Amin MK, Irfan S, Vyas A, Ahsan R, Chaudhary SG, Anwar I, McGuirk M, Iftikhar R, Abdelhakim H, Singh AK, Hamadani M, Mcguirk JP, Mushtaq MU.) Clin Lymphoma Myeloma Leuk. 2025 Aug 17 PMID: 40930936 09/11/2025

  • (Herrera AF, Ansell SM, Zinzani PL, Radford J, Maddocks KJ, Pinto A, Collins GP, Bachanova V, Bartlett NL, Bence-Bruckler I, Hamadani M, Kline J, Mayer J, Savage KJ, Advani RH, Caimi PF, Casasnovas O, Feldman TA, Hess BT, Bastos-Oreiro M, Iyengar S, Szomor Á, Townsend W, André M, Dyczkowski J, Havenith K, Toukam M, Pantano S, Cruz HG, Wang L, Negievich Y, Lucero M, Wuerthner JU, Carlo-Stella C.) Blood Adv. 2025 Aug 14 PMID: 40811783 08/14/2025

  • (Nadiminti KV, Ahn KW, Patel J, Lian Q, Bezerra E, Chen A, Ganguly S, Gergis U, Hashmi H, Kharfan-Dabaja MA, Kuruvilla J, Lekakis L, Locke FL, Murthy H, Mousthafa MA, Perales MA, Pophali P, Riedell PA, Shah NN, Wang T, Pasquini M, Hamadani M, Turtle CJ, Herrera AF, Shadman M.) Transplant Cell Ther. 2025 Aug 05 PMID: 40754223 SCOPUS ID: 2-s2.0-105019071503 08/04/2025

Publications of from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.